Changes in plasma amino acids during conditioning therapy prior to bone marrow transplantation: their relevance to antioxidant status
Hunnisett A G, Kars A, Howard J, Davies S
Amino Acids 1993;4:177-185
Bone marrow transplant (BMT) recipients undergo a bimodal regimen of conditioning therapy, the precise prescription being dependent upon the primary disease of the individual patient. Generally, this treatment consists of chemotherapy and total blood irradiation prior to transplantation, although the latter may or may not be included in the regimen. We have investigated amino acid metabolism and oxidant status in a small series of BMT recipients before and after conditioning therapy.
Plasma amino acids were measured by HPLC on 10 BMT recipients prior to commencing conditioning therapy, and again one week later before transplantation. In addition some general nutritional parameters and antioxidant components were measured. A marked decrease in the plasma concentration of a number of amino acids, especially those concerned with antioxidants, was observed over the 7 days of conditioning therapy.
There is also a significant reduction in antioxidant capability, as reflected by measurements of glutathione and erythrocyte glutathione peroxidase (GSH-Px), which may have an influence upon post-transplant recovery and graft function. Such a reduction in antioxidant concentrations may also have an influence upon the erythrocyte and platelet support required post-grafting.
The data presented in this paper adds to the evidence for the conditional essentiality of some amino acids such as taurine and glutamine, and may support the case for specific antioxidant intervention treatment prior to, and/or after conditioning therapy together with monitoring antioxidant status during the post-grafting period.
NOTICE : Biolab Limited has gone into administration
14th July 2022
Biolab Limited has gone into administration due to the delay by The Care Quality Commission in processing our application to transfer our business activities to our laboratory site in West London following an earlier temporary suspension.
We always remained highly confident that Biolab would reopen and invested heavily in relocating the business, retaining and retraining our employees, developing new and improved methods of work and updating our documentation, so this comes as a huge disappointment for us all, but as you’ll appreciate no business can continue indefinitely without an income.
We are no longer able to process any samples for testing.
Biolab is very proud of the help we have given to hundreds of thousands of patients over 37 years, and we thank everyone for their phenomenal support and loyalty over the years, and for the hundreds of messages of support we have received in recent months.